http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5789244

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Research Support, Non-U.S. Gov't
endingPage 677
issn 1432-1041
0031-6970
issueIdentifier 9
pageRange 673-677
publicationName European Journal of Clinical Pharmacology
startingPage 673
bibliographicCitation Lugardon S, Lapeyre-Mestre M, Montastruc JL, The French Network of Regional Pharmacovigilance Centres. Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database. European Journal of Clinical Pharmacology. 2004 Oct 23;60(9):673–7. doi: 10.1007/s00228-004-0813-5.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec38c944d44332ea56f0161ab69142f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27ed7d7331af9c0c53bdf7e574d70d67
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb0cc59b217067e0beb34d8a5dff9beb
date 2004-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s00228-004-0813-5
https://pubmed.ncbi.nlm.nih.gov/15517227
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3612
https://portal.issn.org/resource/ISSN/1432-1041
https://portal.issn.org/resource/ISSN/0031-6970
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database
discusses http://id.nlm.nih.gov/mesh/M0013341
http://id.nlm.nih.gov/mesh/M0300376
http://id.nlm.nih.gov/mesh/M0276185
http://id.nlm.nih.gov/mesh/M0258705
http://id.nlm.nih.gov/mesh/M0020791
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0025664
http://id.nlm.nih.gov/mesh/M0017803
http://id.nlm.nih.gov/mesh/M0480958
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0446346
http://id.nlm.nih.gov/mesh/M0012175
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5090
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7500

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129203714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881

Total number of triples: 48.